The diagnostic dilemma in a patient with neuroleptic malignant syndrome during the COVID ‐19 pandemic: A significant increase in acute phase reactants
This article describes a woman treated with haloperidol, perphenazine, escitalopram, and alprazolam because she developed catatonic symptoms after psychological stress. She suffered from NMS symptoms and had elevated CRP and ESR levels, among other signs and symptoms. Given the COVID-19 pandemic and reports of co-occurrence of catatonia and NMS and COVID-19 and elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), this patient was a diagnostic dilemma. After consultation with the consultation-liaison psychiatry units, she was managed adequately with electroconvulsive therapy and lorazepam.
Source: Clinical Case Reports - Category: General Medicine Authors: Forouzan Elyasi,
Mehran Zarghami,
Arghavan Fariborzifar,
Hamed Cheraghmakani,
Mahboobeh Shirzad,
Feteme Kazempour Tags: CASE REPORT Source Type: research
More News: Alprazolam | Ativan | Brain | Cancer & Oncology | COVID-19 | Electroconvulsive Therapy | General Medicine | Lexapro | Lorazepam | Men | Neurology | Pandemics | Psychiatry | Psychology | Xanax